Last edition
News about "GLP-1 therapies "
Biohaven Completes Enrollment in Phase II Trial of Taldefgrobep for Obesity
Biohaven finishes enrollment in Phase II study of taldefgrobep, a novel therapy targeting fat loss and muscle gain, with topline data expected in the second half of 2026.
GLP-1 Therapies | 21/03/2026 | By News Bureau | 165
TempraMed Technologies Inks Distribution Agreement with Guri
The partnership marks TempraMed’s entry into a broader global rollout, with the Guri agreement serving as the first step in a series of regional distribution deals planned across Europe, the Middle East, North America, and Asia.
GLP-1 Therapies | 28/11/2025 | By Dineshwori | 160
BioNxt Begins Lab-Scale ODF Development After Receiving Semaglutide API
BioNxt Solutions has received the Semaglutide active pharmaceutical ingredient (API), enabling the initiation of laboratory-scale formulation and testing of its oral dissolvable film (ODF) delivery system.
GLP-1 Therapies | 03/09/2025 | By Dineshwori | 452
Aardvark Therapeutics Secures USD 85 Million Oversubscribed Series C Financing
Aardvark Therapeutics, Inc. has received an USD 85 million oversubscribed Series C financing led by Decheng Capital.
GLP-1 Therapies | 10/05/2024 | By Aishwarya | 443
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy